(Q40812031)

23 September 2017

1 reference

title

The anti-tumour and proinflammatory actions of IL4. (English)

1 reference

23 September 2017

R I Tepper

1

1 reference

23 September 2017

publication date

1 October 1993

1 reference

23 September 2017

published in

Research in Immunology

1 reference

23 September 2017

volume

144

1 reference

23 September 2017

issue

8

1 reference

23 September 2017

page(s)

633-637

1 reference

Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

An eosinophil-dependent mechanism for the antitumor effect of interleukin-4

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

Modulation of tumor-infiltrating lymphocytes derived from human renal cell carcinoma by interleukin-4

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

Redesigning nature's poisons to create anti-tumor reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

Recombinant human interleukin 5 is a selective eosinophil chemoattractant

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2494%2805%2980017-3

7 January 2021

10.1016/S0923-2494(05)80017-3

Identifiers

DOI

1 reference

release_6ost6wuzmrg4rppsa4rz3ciyxi

23 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6ost6wuzmrg4rppsa4rz3ciyxi

24 November 2022

mapped directly with Wikidata item

1 reference